Pages
- 10 Years of Excellence
- About Us
- Adherence Initiative for Medication Management (AIM)
- Awards and Recognition
- Calendar
- California
- Call Me
- Careers
- CareKinesis Video Series: Report Portal
- CII-CIV Med Access
- Clinical Decision Support Tools
- Contact Us
- COVID-19 Resources for PACE
- Education & Events
- EireneRx Access
- EireneRx e-Rx Certification
- EireneRx®
- Emergency Alert
- Enhanced MTM
- Ernest
- For Established PACE Organizations
- Home
- Leadership
- Lillian
- Mary
- MedaCube
- Medication Safety Science Webinar Series
- MedWise Risk Score™ Webinars
- New or Pre-PACE Organizations
- News Items & White Papers
- Opioid Therapy: Using PGx to Improve Outcomes
- Other Services
- PACE Pharmacy Services
- 24/7 PharmD Support and PharmD Consultation
- Case Studies
- A Systematized Approach to Pharmacy
- Eliminating Errors, Reducing Drug Interactions, and Improving Efficiency
- Increasing Medication Management and Adherence with the MedaCube™
- Innovation Exceeding Expectations
- Innovative PACE Medication Management Services
- Innovative PACE Medication Management Services
- Innovative Pharmacy Solutions for a PACE Start-up
- Medication Adherence Programming
- Medications in Transition
- PACE Case Study: Clinical Application of Pharmacogenomics Testing to Reduce Adverse Effects
- PACE Case: Adacel Vs. Boostrix
- PACE Case: Amputation Risk Averted
- PACE Case: Cancer Pain Control
- PACE Case: Cymbalta + Cipro
- PACE Case: Decreasing Competitive Inhibition to Increase Response
- PACE Case: Decreasing Medication-Related Adverse Events
- PACE Case: Diabetes Management
- PACE Case: Diazepam & Verapamil
- PACE Case: Edema
- PACE Case: Falls Assessment
- PACE Case: GERD + HIV Therapy
- PACE Case: Glycemic Control
- PACE Case: Hydrochlorothiazide and Lithium
- PACE Case: Hypomagnesemia
- PACE Case: Improved Pain Control
- PACE Case: Improving Painful Symptoms Associated with Parkinson’s Disease
- PACE Case: Improving Parkinson’s Symptom Control
- PACE Case: Individualizing Medication Recommendations Using Pharmacogenomic Test Results
- PACE Case: Interstitial Nephritis
- PACE Case: Med Interruptions = Relief? (digoxin)
- PACE Case: Medication-Related Fall Risk, Smoking Cessation, and the Risk of Adverse Drug Events
- PACE Case: Mental Health Stabilization and Risk Reduction
- PACE Case: Most Appropriate Antidepressant for a Cardiac Patient
- PACE Case: MRM Opportunities
- PACE Case: Optimizing Medications through Pharmacogenomic Testing
- PACE CASE: Optimizing Pain Management and Deprescribing
- PACE Case: Pain Control ESRD Diabetes
- PACE Case: Pharmacogenomic Testing Utility in Mental Health
- PACE Case: Phenytoin
- PACE Case: Recommending Precautionary Tests
- PACE Case: Reducing Potential Cardiovascular Events
- PACE CASE: Reduction in Medication Burden and Cost Savings
- PACE CASE: Restlessness and Uncontrollable Facial Movements
- PACE Case: Risk Score Reduction Recommendations
- PACE Case: Risperidone Alternatives for Elevated QTc
- PACE Case: Transitioning to a Comfort Care Path
- PACE Case: Treating Infection in Complicated Participant
- PACE CASE: Unexplained Fatigue
- PACE Case: When Citalopram 20mg is not Citalopram 20mg
- Patient Case: Decreasing the Risk of Bleeding, Hypoglycemia, Myopathy, and Excessive Sedation
- Scalable Pharmacy Solutions for ArchCare
- Solutions for a Continuing Care Retirement Community Organization
- Using Technology to Increase Operational Efficiency
- PACE Pharmacy Custom Adherence Packaging
- What is PACE?
- Password Test
- Premium Delivery Service
- Press Releases
- Privacy Policy
- Restless Leg Syndrome (RLS)
- Security
- Sitemap
- Terms
- Thank You
- The Case for Pharmacogenomic Testing for All PACE Participants
- What is a cookie?
